Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adamas Pharmaceuticals
Adamas Pharmaceuticals
(ADMS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fluzone
pneumonia
,
pneumococcal pneumonia
,
haemophilus influenzae
,
streptococcus pneumoniae
,
virus diseases
,
chronic obstructive pulmonary disease
,
respiration disorders
,
arthralgia
,
dengue
,
rotavirus infections
,
haemophilus infections
,
neisseria meningitidis
,
respiratory syncytial virus infections
,
influenza in birds
,
herpes zoster
,
tetanus
,
diphtheria
,
meningococcal infections
,
respiratory tract diseases
,
hepatitis b
,
poliomyelitis
,
pneumococcal infections
,
orthomyxoviridae infections
,
gram-negative bacterial infections
,
whooping cough
,
hepatitis
,
herpes simplex
,
hepatitis a
,
covid-19
,
human influenza
,
haemophilus influenzae type b
,
infections
,
h1n1 subtype influenza a virus
,
common cold
,
healthy volunteers/patients
,
hiv infections
,
otitis media
,
respiratory tract infections
,
communicable diseases
,
disease progression
,
sinusitis
,
asthma
,
bronchitis
,
bronchial spasm
,
multiple sclerosis
,
sclerosis
,
narcolepsy
,
myositis
,
fever
,
infectious encephalitis
,
immunologic tests
,
malaria
,
meningitis
,
otitis
,
emergencies
,
drug-related side effects and adverse reactions
,
vaccine-preventable diseases
Flumist
obesity
,
influenza a virus
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
,
human influenza
,
respiratory tract infections
,
critical illness
,
virus diseases
,
infections
,
communicable diseases
,
herpesviridae infections
,
influenza b virus
,
respiratory syncytial virus infections
,
emergencies
Flucelvax
healthy volunteers/patients
,
rheumatoid arthritis
,
arthritis
,
covid-19
,
coronavirus infections
,
respiratory syncytial viruses
,
human influenza
,
pneumococcal infections
,
pneumococcal pneumonia
,
streptococcus pneumoniae
,
h1n1 subtype influenza a virus
Isoxaflutole
healthy volunteers/patients
,
myelodysplastic syndromes
,
neoplasms
,
myeloproliferative disorders
,
myelodysplastic-myeloproliferative diseases
,
myeloid leukemia
,
leukemia
,
myeloid leukemia acute
,
monocytic leukemia acute
,
non-hodgkin lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
burkitt lymphoma
,
macular edema
,
parkinson disease
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use